Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016;15(2):265-73.
doi: 10.1517/14740338.2016.1128412. Epub 2015 Dec 23.

Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention

Kenneth K Mugwanya  1   2   3 , Jared M Baeten  1   2   4
Affiliations
Review

Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention

Kenneth K Mugwanya et al. Expert Opin Drug Saf. 2016.

Abstract

Introduction: Tenofovir disoproxil fumarate (TDF)-based pre-exposure prophylaxis is a novel HIV prevention strategy for individuals at increased sexual risk for HIV infection. For any biomedical prevention intervention, the bar for tolerating adverse effects in healthy persons is high compared to therapeutic interventions.

Areas covered: We provide a concise summary of the clinical safety of TDF-based pre-exposure prophylaxis with focus on TDF-related effects on tolerability, kidney function, bone density, HIV resistance, sexual and reproductive health. The evidence base for this review is derived from a literature search of both randomized and observational studies evaluating efficacy and safety of TDF-based PrEP, TDF alone or in combination with emtricitabine, identified from PUBMED and EMBASE electronic databases, clinicaltrials.gov and major HIV conferences.

Expert opinion: TDF-based pre-exposure prophylaxis is a potent intervention against HIV acquisition when taken which is generally safe and well tolerated. The risk of the small, non-progressive, and reversible decline in glomerular filtration rate and bone mineral density as well as the potential selection for drug resistance associated with PrEP are outweighed, at the population level and broadly for individuals, by PrEP's substantial reduction in the risk of HIV infection.

Keywords: HIV prevention; PrEP; Safety of PrEP; TDF; Tenofovir disoproxil fumarate; pre-exposure prophylaxis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. N. Engl. J. Med. 2012;367(5):399–410. **First generation pitoval PrEP efficacy and saftey trial in heterosexual men and women with the highest adherence of any PrEP trial.

    1. Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. 2013;381(9883):2083–2090. * Demostrated PrEP efficacy and saftey trial in injection drug users.

    1. Grant RM, Lama JR, Anderson PL, et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. N. Engl. J. Med. 2010;363(27):2587–2599. ** First generation pivotal PrEP efficacy and saftey trial in heterosexual persons.

    1. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana. N. Engl. J. Med. 2012;367(5):423–434. - PubMed
    1. Cooper RD, Wiebe N, Smith N, Keiser P, Naicker S, Tonelli M. Systematic Review and Meta-analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV-Infected Patients. Clin. Infect. Dis. 2010;51(5):496–505. - PubMed

Publication types

MeSH terms

LinkOut - more resources